Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/Naloxone in Chronic Cancer Pain
NCT00513656Phase 2Completed
- Sponsor
- Mundipharma
- Start
- Sep 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of oxycodone + naloxone in cancer pain, sponsored by Mundipharma. Started Sep 2007; status: completed.
02
Drugs
oxycodone + naloxone
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00513656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00513656.